March 4, 2011 --
San Diego -- Volcano Corporation (Nasdaq: VOLC),
a leading developer and manufacturer of precision guided
therapy tools designed to enhance the diagnosis and treatment
of coronary and peripheral vascular disease, announced today
that it received clearance to market the Eagle Eye® Platinum
digital IVUS catheter in Japan, and will introduce the device
at the 20th PCI Live Demonstration Course in Kurashiki, which
starts on March 3rd. This state-of-the-art catheter offers
all of the benefits of the predecessor Eagle Eye® Gold catheter,
plus improved deliverability and the convenience of additional
radiopaque markers. Full market release of Eagle Eye® Platinum
in Japan is expected in the second quarter of 2011.
|